Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?
Main Authors: | Kinrin Yamanaka, Nimrat Chatterjee, Michael T Hemann, Graham C Walker |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-08-01
|
Series: | PLoS Genetics |
Online Access: | http://europepmc.org/articles/PMC5560539?pdf=render |
Similar Items
-
Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?
by: Yamanaka, Kinrin, et al.
Published: (2018) -
A stapled POL κ peptide targets REV1 to inhibit mutagenic translesion synthesis
by: Chatterjee, Nimrat, et al.
Published: (2021) -
Error-prone translesion synthesis mediates acquired chemoresistance
by: Xie, Kun, et al.
Published: (2014) -
Proteasomal regulation of the mutagenic translesion DNA polymerase, Saccharomyces cerevisiae Rev1
by: Wiltrout, Mary Ellen, et al.
Published: (2015) -
A comprehensive strategy to discover inhibitors of the translesion synthesis DNA polymerase κ.
by: Kinrin Yamanaka, et al.
Published: (2012-01-01)